MCLENA-1: A phase ii clinical trial for the assessment of safety, tolerability, and efficacy of lenalidomide in patients with mild cognitive impairment due to alzheimer’s disease

Boris Decourt, Jeffrey Wilson, Aaron Ritter, Christopher Dardis, Frank P. Difilippo, Xiaowei Zhuang, Dietmar Cordes, Garam Lee, Nadia D. Fulkerson, Tessa St Rose, Katurah Hartley, Marwan N. Sabbagh

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'MCLENA-1: A phase ii clinical trial for the assessment of safety, tolerability, and efficacy of lenalidomide in patients with mild cognitive impairment due to alzheimer’s disease'. Together they form a unique fingerprint.

Medicine & Life Sciences